FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35819511000001101: Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
109999401000001113 Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109999501000001112 Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Is a Rucaparib 200mg tablets 60 tablet true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Has AMP Rubraca 200mg tablets (Clovis Oncology UK Ltd) true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Has specific active ingredient Rucaparib camsilate true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rucaparib true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rubraca 200mg tablets (Clovis Oncology UK Ltd) 60 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start